FGF21 and metabolic dysfunction-associated steatotic liver disease: Hepatic FGF21 expression is positively related with adipocity and intrahepatic triglycerids, and its serum levels are significantly increased in patiens with obesity, NAFLD, and type 2 diabetes [326,327,328].